URSO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 680
EU - Europa 210
AS - Asia 117
OC - Oceania 1
Totale 1.008
Nazione #
US - Stati Uniti d'America 679
IT - Italia 87
CN - Cina 52
TR - Turchia 36
SE - Svezia 27
GB - Regno Unito 26
DE - Germania 21
BE - Belgio 18
SG - Singapore 17
UA - Ucraina 12
PL - Polonia 8
ID - Indonesia 5
VN - Vietnam 5
CZ - Repubblica Ceca 3
FR - Francia 3
FI - Finlandia 2
JP - Giappone 2
AT - Austria 1
AU - Australia 1
CA - Canada 1
EE - Estonia 1
IE - Irlanda 1
Totale 1.008
Città #
Fairfield 109
Woodbridge 102
Ann Arbor 72
Ferrara 58
Chandler 54
Ashburn 48
Houston 40
Seattle 39
Cambridge 35
Wilmington 26
New York 20
Jacksonville 19
Brussels 18
Izmir 14
Beijing 13
Nanjing 12
Shanghai 12
Princeton 11
Singapore 11
Addison 10
Bremen 10
Milan 10
Warsaw 8
Boardman 7
Dong Ket 5
Jakarta 5
San Diego 5
Shenyang 4
Tianjin 4
Brno 3
Ningbo 2
Redmond 2
Rome 2
Traversetolo 2
Acton 1
Anzola Dell'emilia 1
Berlin 1
Cattolica 1
Changsha 1
Des Moines 1
Dublin 1
Edinburgh 1
Falls Church 1
Hebei 1
Hounslow 1
Jinan 1
Kunming 1
London 1
Nanchang 1
Norwalk 1
Orange 1
Parma 1
Tallinn 1
Toronto 1
Vienna 1
Totale 813
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 179
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 122
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 119
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 115
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 106
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 94
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 70
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 61
Spontaneously reversible adrenal nodules in primary diffuse large B-cell testicular lymphoma mimicking an extranodal involvement: A case report 44
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency 9
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era 2
Totale 1.036
Categoria #
all - tutte 5.181
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.181


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020221 30 5 14 27 20 27 28 18 26 12 7 7
2020/2021182 4 23 13 11 4 9 18 14 6 49 14 17
2021/2022154 8 8 5 8 9 7 32 11 3 6 21 36
2022/2023138 13 16 9 18 17 25 11 6 16 0 4 3
2023/202493 6 9 2 2 11 27 3 6 1 2 1 23
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.036